Mark Newman - 09 Jun 2023 Form 4/A - Amendment Insider Report for Chemours Co (CC)

Reporting relationship: President and CEO, Director
Issuer ticker: CC
Reported as of: 09 Jun 2023
Net transaction value: +$249,978
SEC form: 4/A - Amendment
Accepted by SEC: 12 Jun 2023, 10:45:41 UTC
Original report date: 12 Jun 2023
Prior SEC filing: 10 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Pauletta Brown, Attorney-in-fact

Key filing fact

Mark Newman filed Form 4/A - Amendment for Chemours Co (CC) on 12 Jun 2023.

Key facts

This page summarizes Mark Newman's Form 4/A - Amendment filing for Chemours Co (CC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2023, 10:45.

Change

Previous filing in this sequence was filed on 10 Mar 2023.
Current net transaction value: +$249,978.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Purchase

Transaction value: $249,978
Shares: +7,661
Change %: +3%
Price: $32.63
Shares after: 266,955
Date: 09 Jun 2023
Ownership: Direct
Footnotes: F1, F2

CC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,480
Date: 09 Jun 2023
Ownership: Reporting person's children

CC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,155
Date: 09 Jun 2023
Ownership: By GRAT

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The original Form 4, filed on June 12, 2023, is amended by this Form 4 amendment solely to correct the price of reported stock purchased.

Footnote F2

Includes directly owned shares, restricted stock units and dividend equivalent units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .